⚠️ This provider averages 1.2K services per working day — physically unusual for an individual practitioner
Based on 2.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $34.3M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.2K services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $22.65 | $11.82 | 1.92x | $10.83 | $2.6M | 220.1K | 42 |
| 2015 | $19.93 | $11.89 | 1.68x | $8.04 | $2.8M | 236.9K | 44 |
| 2016 | $25.39 | $12.42 | 2.04x | $12.97 | $2.4M | 196.5K | 45 |
| 2017 | $24.03 | $12.68 | 1.90x | $11.35 | $3.3M | 262.6K | 44 |
| 2018 | $22.14 | $12.30 | 1.80x | $9.84 | $3.9M | 318.7K | 46 |
| 2019 | $22.05 | $11.33 | 1.95x | $10.72 | $3.7M | 328.0K | 42 |
| 2020 | $18.36 | $11.56 | 1.59x | $6.80 | $5.1M | 440.3K | 44 |
| 2021 | $21.25 | $12.60 | 1.69x | $8.65 | $3.5M | 274.9K | 46 |
| 2022 | $20.68 | $12.49 | 1.66x | $8.19 | $3.7M | 295.6K | 44 |
| 2023 | $16.26 | $10.05 | 1.62x | $6.21 | $3.2M | 321.4K | 38 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 114.7K | $4.7M | $40.58 | 1.40x |
| J9145 | Injection, daratumumab, 10 mg | 52.4K | $2.1M | $40.85 | 1.49x |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 50.0K | $1.8M | $36.37 | 1.68x |
| J0897 | Injection, denosumab, 1 mg | 108.8K | $1.7M | $15.25 | 1.41x |
| J9299 | Injection, nivolumab, 1 mg | 74.3K | $1.6M | $21.71 | 1.46x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 166.2K | $1.5M | $9.00 | 2.30x |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 41.9K | $1.3M | $30.09 | 2.78x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 14.4K | $1.3M | $87.14 | 1.36x |
| J9035 | Injection, bevacizumab, 10 mg | 21.6K | $1.2M | $57.57 | 1.52x |
| J9310 | Injection, rituximab, 100 mg | 2.1K | $1.2M | $592.94 | 1.45x |
| J9041 | Injection, bortezomib, 0.1 mg | 36.5K | $1.2M | $32.08 | 1.77x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 112.7K | $967.2K | $8.58 | 1.64x |
| J9355 | Injection, trastuzumab, 10 mg | 11.3K | $779.1K | $69.11 | 1.55x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 6.6K | $771.1K | $116.11 | 1.27x |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 108.3K | $762.5K | $7.04 | 2.07x |
| J2505 | Injection, pegfilgrastim, 6 mg | 244 | $739.1K | $3.0K | 1.88x |
| J1556 | Injection, immune globulin (bivigam), 500 mg | 12.4K | $692.7K | $56.00 | 1.43x |
| J9395 | Injection, fulvestrant, 25 mg | 9.3K | $593.7K | $63.74 | 1.73x |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g. liquid), 500 mg | 18.8K | $588.0K | $31.27 | 2.04x |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 617.3K | $530.5K | $0.86 | 1.85x |
This provider submits charges 1.77 times higher than what Medicare actually pays.
A markup ratio of 1.77x means for every $100 Medicare pays, this provider initially charges $177. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Luke Dreisbach, M.D. | Rancho Mirage, CA | $77.2M | ✓ Clear |
| Sachin Gupta, M.D. | Fresno, CA | $55.1M | ✓ Clear |
| Ravi Rao, MD | Fresno, CA | $49.1M | ⚠️ Flagged |
| Michael Sherman, M.D., PHD | Walnut Creek, CA | $38.9M | ✓ Clear |
| Nerses Tchekmedyian, M.D. | Irvine, CA | $38.0M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data